Financial News

Epizyme CEO to step down as company plans to extend cancer drug's reach

After six years in the CEO position, Epizyme leader Robert Bazemore is stepping aside, moving into a consultant role as biotech veteran Grant Bogle takes the reins.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Feedback